SCHEMBL2550198

SCHEMBL2550198

CC(CNC(=O)O)c1ccc(B2OC(C)(C)C(C)(C)O2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 7/20 0.43
LPL P06858 6/20 0.43
ESR2 Q92731 1/20 0.43
P4HB P07237 1/20 0.41
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA9 Q16790 4/20 0.41
F11 P03951 3/20 0.40
F2 P00734 2/20 0.40
PRSS1 P07477 2/20 0.40
PRSS2 P07478 2/20 0.40
PRSS3 P35030 2/20 0.40
CA12 O43570 1/20 0.40
CA3 P07451 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CA5B Q9Y2D0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2553821 0.86 P4HB (0.42) LIPGLPLESR2P4HBCA1
SCHEMBL2546307 0.84 LIPG (0.42) LIPGLPLESR2P4HBCA1
SCHEMBL15189795 0.83 AAK1 (0.43) LIPGLPLESR2P4HBCA1
SCHEMBL1141513 0.82 AAK1 (0.55) LIPGLPLESR2CA1CA2
SCHEMBL2553319 0.82 AAK1 (0.55) LIPGLPLESR2CA1CA2
SCHEMBL2560306 0.82 AAK1 (0.55) LIPGLPLESR2CA1CA2
SCHEMBL15777574 0.81 FFAR1 (0.48) LIPGLPLESR2P4HBCA1
SCHEMBL2551126 0.81 AAK1 (0.41) LIPGLPLESR2P4HBCA1
SCHEMBL16611798 0.80 MTNR1A (0.48) LIPGLPLP4HBCA1CA2
SCHEMBL2554622 0.80 ROCK1 (0.43) LIPGLPLP4HBCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2552206-A1 TRYCYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME OncoTherapy Science, Inc. (JP) 2013-02-06 EP disclosed
WO-2011123419-A1 TRYCYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2011-10-06 WO disclosed